Terms such as "opioid McCarthyism" and "witch hunt" were used to express frustration with current opioid regulatory efforts.
Kenneth J. Bender, PharmD, MA
From PAINWeek 2017: Reflex vasodilation is out, neurobiologic dysfunction is in as explanation for migraine etiology.
An early session at PAINWeek 2017 addressed prescriber fear as regulatory agencies "pile on" across overlapping jurisdictions.
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.
Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.
A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.
When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.